Skip to main content Accessibility help

Obsessive—Compulsive Disorder as a 5-HT Subsystem-Related Behavioural Disorder

  • D. L. Murphy (a1), J. Zohar (a2), C. Benkelfat (a1), M. T. Pato (a1), T. A. Pigott (a1) and T. R. Insel (a1)...


Involvement of the brain serotonin (5-HT) neurotransmitter system in obsessive-compulsive disorder (OCD) was originally suggested on the basis of therapeutic effects found with the semi-selective serotonin uptake inhibitor, clomipramine. More recent studies directly comparing clomipramine with non-selective or norepinephrine-selective uptake inhibitors, such as desipramine or nortriptyline, as well as studies with new, more selective serotonin uptake inhibitors, including fluvoxamine and fluoxetine, have supported that hypothesis. Clomipramine's antiobsessional effect has been augmented with the serotonin precursor, L-tryptophan, or with lithium, which has prominent serotonergic effects. Patients whose OCD symptoms improved on clomipramine worsened when the drug was discontinued (regardless of duration of therapy) and improved when clomipramine was reinstituted. OCD symptoms also worsened when metergoline, a 5-HT antagonist, was given to patients who had improved with clomipramine. Metergoline given alone had no effect. Administration of m-chlorophenylpiperazine (m-CPP), a 5-HT receptor agonist, to untreated OCD patients increased their anxiety, depression, and dysphoria, and exacerbated their OC symptoms. After 4 months of clomipramine therapy, m-CPP failed to produce the same behavioural effects, suggesting an alteration of a 5-HT subsystem (possibly downregulation of some 5-HT receptors). The data reviewed suggest an important role for an abnormal brain 5-HT subsystem in patients with OCD.


Corresponding author



Hide All
Aloi, J. A., Insel, T. R., Mueller, E. A., et al (1984) Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys. Life Sciences, 34, 13251331.
Ananth, J., Pecknold, J. C., van den Steen, N., et al (1981) Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Progress in Neuro-psychopharmacology and Biological Psychiatry, 5, 257262.
Baxter, L. R., Phelps, M. E., Mazziotta, J. C., et al (1987) Local cerebral glucose metabolic rates in obsessive—compulsive disorder: a comparison with rates in unipolar depression and in normal controls. Archives of General Psychiatry, 44, 211218.
Benkelfat, C., Murphy, D. L., Zohar, J., et al (1989) Clomipramine in obsessive-compulsive disorder: further evidence for a serotonergic mechanism of action. Archives of General Psychiatry, 46, 2328.
Blier, P. & De Montigny, C. (1985) Short-term lithium administration enhances serotonergic neurotransmission: electrophysiological evidence in the rat CNS. European Journal of Pharmacology, 113, 6979.
Caccia, S., Ballabio, M., Samanin, R., et al (1981) (–)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone. Journal of Pharmacy and Pharmacology, 33, 477478.
Charney, D. S., Goodman, W. K., Price, L. H., et al (1988) Serotonin function in obsessive–compulsive disorder: a comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Archives of General Psychiatry, 45, 177185.
Eisenberg, J. & Asnis, G. (1985) Lithium as an adjunct treatment in obsessive–compulsive disorder. American Journal of Psychiatry, 142, 663.
Engelman, K., Lovenberg, W. & Sjoerdsma, A. (1967) Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome. New England Journal of Medicine, 211, 11031108.
Fernández Córdoba, E. & López-Ibor Aliño, J. (1967) Clomipramine in resistant psychiatric disorders and other treatments. Actos Luso-Españolas de Neurologia, Psiquiatria y Ciencias Afines, 26, 119147.
Fernstrom, J. D. & Wurtman, R. J. (1974) Nutrition and the brain. Scientific American, 230, 8491.
Flament, M. F., Rapoport, J. L., Berg, C. J., et al (1985) Clomipramine treatment of childhood obsessive—compulsive disorder: a double-blind controlled study. Archives of General Psychiatry, 42, 977983.
Flament, M. F., Rapoport, J. L., Murphy, D. L., et al (1987) Biochemical changes during clomipramine treatment of childhood obsessive—compulsive disorder. Archives of General Psychiatry, 44, 219225.
Frazer, A. & Brunswick, D. J. (1989) Antidepressant drugs. In Basic Pharmacology and Medicine 3rd edn (eds DiPalma, J. R. & DiGregor, G. J.). New York: McGraw-Hill.
Frazer, A., Offord, S. J. & Lucki, I. (1989) Regulation of serotonin receptors and responsiveness in the brain. In The Serotonin Receptors (ed., Sanders-Bush, E.). Clifton: Humana Press Inc.
Fuller, R. W., Mason, N. R. & Molloy, B. B. (1980) Structural relationships in the inhibition of [3H]serotonin binding to rat brain membranes in vitro by 1-phenyl-piperazines. Biochemical Pharmacology, 29, 833835.
Fuller, R. W., Snoddy, H. D., Mason, N. R., et al (1981) Disposition and pharmacological effects of m-chlorophenylpiperazine in rats. Neuropharmacology, 20, 155162.
Fuxe, K., Ögren, S.-O., Agnati, L. F., et al (1983) Chronic antidepressant treatment and central 5-HT synapses. Neuropharmacology, 22, 389400.
Goodman, W. K., Price, L. H., Rasmussen, S. A., et al (1989) Efficacy of fluvoxamine in obsessive—compulsive disorder: a double-blind comparison with placebo. Archives of General Psychiatry, 46, 3644.
Gorman, J. M., Liebowitz, M. R., Fyer, A. J., et al (1985) Lactate infusions in obsessive—compulsive disorder. American Journal of Psychiatry, 142, 864866.
Heym, J. & Koe, B. K. (1988) Pharmacology of sertraline: a review. Journal of Clinical Psychiatry, 49:8 (Suppl.), 4045.
Hollander, E., Fay, M., Cohen, B., et al (1988) Serotonergic and noradrenergic sensitivity in obsessive—compulsive disorder: behavioral findings. American Journal of Psychiatry, 145, 10151017.
Hyttel, J. & Larsen, J.-J. (1985) Serotonin-selective antidepressants. Acta Pharmacologica et Toxicologia, 56 (Suppl. 1), 146153.
Insel, T. R. & Murphy, D. L. (1981) The psychopharmacological treatment of obsessive-compulsive disorder: a review. Journal of Clinical Psychopharmacology, 1, 304311.
Insel, T. R., Murphy, D. L., Cohen, R. M., et al (1983) Obsessive-compulsive disorder: a double-blind trial of clomipramine and clorgyline. Archives of General Psychiatry, 40, 605612.
Insel, T. R., Mueller, E. A. III, Gillin, J. C., et al (1984) Biological markers in obsessive—compulsive and affective disorders. Journal of Psychiatric Research, 18, 407423.
Insel, T. R., Mueller, E. A. III, Alterman, I., et al (1985) Obsessive—compulsive disorder and serotonin: is there a connection? Biological Psychiatry, 20, 11741188.
Invernizzi, R., Cotecchia, S., De Blasi, A., et al (1981) Effects of m-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in rats. Neurochemistry International, 3, 239244.
Jimerson, D. C. & Berrettini, W. (1985) Cerebrospinal fluid amine metabolite studies in depression: research update. In Pathochemical Markers in Major Psychoses (eds Beckmann, H. & Riederer, P.). Berlin: Springer Verlag.
Kahn, R. S., Asnis, G. M., Wetzler, S., et al (1988a) Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Psychopharmacology, 96, 360364.
Kahn, R. S., Wetzler, S., van Praag, H. M., et al (1988b) Behavioral indications for serotonin receptor hypersensitivity in panic disorder. Psychiatry Research, 25, 101104.
Karno, M., Golding, J. M., Sorenson, S. B., et al (1988) The epidemiology of obsessive—compulsive disorder in five US communities. Archives of General Psychiatry, 45, 10941099.
Leonard, H., Swedo, S., Rapoport, J. L., et al (1988) Treatment of childhood obsessive—compulsive disorder with clomipramine and desmethylimipramine: a double-blind crossover comparison. Psychopharmacology Bulletin, 24, 9395.
Liebowitz, M. R., Fyer, A. J., Gorman, J. M., et al (1988) Tricyclic therapy of the DSM-III anxiety disorders: a review with implications for further research. Journal of Psychiatric Research, 22, 731.
Lingjærde, O. (1984) Blood platelets as a model system for studying the biochemistry of depression. In Frontiers in Biochemical and Pharmacological Research in Depression: Advances in Biochemical Psychopharmacology (eds Usdin, E., Åsberg, M., Bertilsson, L., et al), Vol. 39. New York: Raven Press.
Linnoila, M., Virkkunen, M., Scheinin, M., et al (1983) Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sciences, 33, 26092614.
López-Ibor, J. J. Jr. (1988) The involvement of serotonin in psychiatric disorders and behaviour. British Journal of Psychiatry, 153 (Suppl. 3), 2639.
Maj, J. & Lewandowska, A. (1980) Central serotoninmimetic action of phenylpiperazines. Polish Journal of Pharmacology and Pharmacy, 32, 495504.
Marks, I. M., Stern, R. S., Mawson, D., et al (1980) Clomipramine and exposure for obsessive—compulsive rituals: I. British Journal of Psychiatry, 136, 125.
Mavissakalian, M., Turner, S. M., Michelson, L. & Jacob, R. (1985) Tricyclic antidepressants in obsessive—compulsive disorder: antiobsessional or antidepressant agents? II. American Journal of Psychiatry, 142, 572576.
Meltzer, H. Y., Witta, B., Tricou, B. J., et al (1982) Effect of serotonin precursors and serotonin agonists on plasma hormone levels. In Serotonin in Biological Psychiatry (eds Ho, B. T., Schoolar, J. C. & Usdin, E.). New York: Raven Press.
Mennini, T., Poggesi, E., Caccia, S., et al (1980) Adaptive changes in central serotonin receptors after long-term drug treatment in rats. In Neurotransmitters and Their Receptors (eds Littauer, U.Z., Dudai, Y., Silman, I., et al). New York: John Wiley & Sons, Ltd.
Mills, F. J. (1985) The endocrinology of stress. Aviation, Space, and Environmental Medicine, 56, 642650.
Montgomery, S. A. (1980) Clomipramine in obsessional neurosis: A placebo-controlled trial. Pharmaceutical Medicine, I, 189192.
Mueller, E. A., Murphy, D. L. & Sunderland, T. (1985a) Neuroendocrine effects of m-chlorophenylpiperazine, a serotonin agonist, in humans. Journal of Clinical Endocrinology and Metabolism, 61, 11791184.
Mueller, E. A., Murphy, D. L., Sunderland, T. et al (1985b) A new postsynaptic serotonin receptor agonist suitable for studies in humans. Psychopharmacology Bulletin, 21, 701704.
Mueller, E. A., Murphy, D. L., Sunderland, T. (1986) Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans. Psychopharmacology, 89, 388391.
Murphy, D. L., Mueller, E. A., Hill, J. L., et al (1989) Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers. Psychopharmacology, 98, 275282.
Nordahl, T. E., Benkelfat, C., Semple, W., et al (1989) Cerebral glucose metabolic rates in obsessive—compulsive disorder. Neuropsychopharmacology, 3, 2327.
Ögren, S. O., Fuxe, K. & Agnati, L. (1985) The importance of brain serotonergic receptor mechanisms for the action of antidepressant drugs. Pharmacopsychiatry, 18, 209213.
Pato, M. T., Zohar-Kadouch, R., Zohar, J., et al (1988) Return of symptoms after discontinuation of clomipramine in patients with obsessive—compulsive disorder. American Journal of Psychiatry, 145, 15211525.
Paul, S. M., Rehavi, M., Rice, K. C., et al (1981) Does high affinity [3H] imipramine binding label serotonin reuptake sites in brain and platelet? Life Sciences, 28, 27532760.
Perse, T. L., Greist, J. H., Jefferson, J. W., et al (1987) Fluvoxamine treatment of obsessive—compulsive disorder. American Journal of Psychiatry, 144, 15431548.
Post, R. M. & Murphy, D. L. (1979) Research planning: studies of cerebrospinal fluid metabolites and blood cell enzymes. In Handbook of Biological Psychiatry (ed van Praag, H. M.). New York: Marcel Dekker.
Prasad, A. (1984) A double blind study of imipramine versus zimelidine in treatment of obsessive compulsive neurosis. Pharmacopsychiatry, 17, 6162.
Prasad, A. (1985) Efficacy of trazodone as an anti obsessional agent. Pharmacology, Biochemistry, and Behavior, 22, 347348.
Price, L. H., Charney, D. S., Delgado, P. L., et al (1989) Lithium treatment and serotoninergic function: neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder. Archives of General Psychiatry, 46, 1319.
Rapoport, J., Elkins, R. & Mikkelsen, E. (1980) Clinical controlled trial of chlorimipramine in adolescents with obsessive—compulsive disorder. Psychopharmacology Bulletin, 16, 6163.
Rapoport, J. L. (1988) The neurobiology of obsessive—compulsive disorder. Journal of the American Medical Association, 260, 28802890.
Rasmussen, S. A. (1984) Lithium and tryptophan augmentation in clomipramine-resistant obsessive—compulsive disorder. American Journal of Psychiatry, 141, 12831285.
Rasmussen, S. A., Goodman, W. K., Woods, S. W., et al (1987) Effects of yohimbine in obsessive compulsive disorder. Psychopharmacology, 93, 308313.
Rehavi, M., Skolnick, P. & Paul, S. M. (1984) High-affinity binding sites for tricyclic antidepressants in brain and platelets. In Brain Receptor Methodologies (eds Marangos, P. J., Campbell, I. C. & Cohen, R. M.). Orlando: Academic Press.
Saavedra, J. M. & Axelrod, J. (1974) Brain tryptamine and the effects of drugs. Advances in Biochemical Psychopharmacology, 10, 135139.
Samanin, R., Mennini, T., Ferraris, A., et al (1979) m-Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats. Naunyn-Schmiedeberg's Archives of Pharmacology, 308, 159163.
Samanin, R., Caccia, S., Bendotti, C., et al (1980) Further studies on the mechanism of serotonin-dependent anorexia in rats. Psychopharmacology, 68, 99104.
Stern, R. S., Marks, I. M., Wright, J., et al (1980) Clomipramine: plasma levels, side effects and outcome in obsessive—compulsive neurosis. Postgraduate Medical Journal, 56 (Suppl. 1), 134139.
Stern, T. A. & Jenike, M. A. (1983) Treatment of obsessive-compulsive disorder with lithium carbonate. Psychosomatics, 24, 671673.
Thorén, P., Åsberg, M., Cronholm, B., et al (1980a) Clomipramine treatment of obsessive—compulsive disorder. I. A controlled clinical trial. Archives of General Psychiatry, 37, 12811285.
Thorén, P., Åsberg, M., Bertilsson, L., et al (1980b) Clomipramine treatment of obsessive—compulsive disorder. II. Biochemical aspects. Archives of General Psychiatry, 37, 12891294.
van Praag, H. M. (1983) CSF 5-HIAA and suicide in non-depressed schizophrenics. Lancet, ii, 977978.
Vetulani, J., Sansone, M., Bednarczyk, B., et al (1982) Different effects of 3-chlorophenylpiperazine on locomotor activity and acquisition of conditioned avoidance response in different strains of mice. Naunyn-Schmiedeberg's Archives of Pharmacology, 319, 271274.
Virkkunen, M., Nuutila, A., Goodwin, F. K., et al (1987) Cerebrospinal fluid monoamine metabolite levels in male arsonists. Archives of General Psychiatry, 44, 241247.
Volavka, J., Neziroglu, F. & Yaryura-Tobias, J. A. (1985) Clomipramine and imipramine in obsessive—compulsive disorder. Psychiatry Research, 14, 8391.
Weizman, A., Carmi, M., Hemesh, H., et al (1986) High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive—compulsive patients. American Journal of Psychiatry, 143, 335339.
Yaryura-Tobias, J. A. & Bhagavan, H. N. (1977) l-Trytophan in obsessive—compulsive disorders. American Journal of Psychiatry, 134, 12981299.
Zak, J. P., Miller, J. A. Jr., Sheehan, D. V., et al (1988) The potential role of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder. Journal of Clinical Psychiatry, 49 (8, Suppl.), 2329.
Zohar, J. & Insel, T. R. (1987) Obsessive—compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Biological Psychiatry, 22, 667687.
Zohar, J., Mueller, E. A., Insel, T. R., et al (1987a) Serotonergic responsivity in obsessive—compulsive disorder: comparison of patients and healthy controls. Archives of General Psychiatry, 44, 946951.
Zohar, J., Klein, E. M., Mueller, E. A., et al (1987b) 5HT, obsessive-compulsive disorder and anxiety. 140th Annual Meeting of the American Psychiatric Association, Chicago, IL, May 9–14, 1987. Abstract no. 950, p. 175.
Zohar, J., Insel, T. R., Zohar-Kadouch, R.C., et al (1988) Serotonergic responsivity in obsessive—compulsive disorder: effects of chronic clomipramine treatment. Archives of General Psychiatry, 45, 167172.

Obsessive—Compulsive Disorder as a 5-HT Subsystem-Related Behavioural Disorder

  • D. L. Murphy (a1), J. Zohar (a2), C. Benkelfat (a1), M. T. Pato (a1), T. A. Pigott (a1) and T. R. Insel (a1)...


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Obsessive—Compulsive Disorder as a 5-HT Subsystem-Related Behavioural Disorder

  • D. L. Murphy (a1), J. Zohar (a2), C. Benkelfat (a1), M. T. Pato (a1), T. A. Pigott (a1) and T. R. Insel (a1)...
Submit a response


We encountered an error trying to retrieve eLetters for this article. Please try again or contact Customer Services


Reply to: Submit a response

Your details

Conflicting interests

Do you have any conflicting interests? *